Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

Dec. 12, 1996

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

New antidepressant compounds in development at HMR

Dec. 12, 1996

Positive GABAA receptor complex modulators claimed

Dec. 12, 1996

DepoTech files IND for DepoMorphine

Dec. 11, 1996

New neurotensin receptor ligands from Sanofi

Dec. 11, 1996

Knoll claims potential anticonvulsants

Dec. 11, 1996

Paracetamol safety established in pregnant mothers and their babies

Dec. 10, 1996

FDA approves new agent for spasticity

Dec. 10, 1996

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...